Category: Federal Forum Posters
Purpose: To improve quality of care of veteran receiving Naltrexone ER treatment by appropriate monitoring, and increasing follow-up doses after initiation. Primary objective is to determine if appropriate monitoring parameters were utilized in initiation of Naltrexone ER therapy. Secondary objectives include determining the number of patients receiving one-time doses, Clinical Opiate Withdrawal Scale (COWS) score at time of initiation of Naltrexone ER, the percentage of abstinence, and the percentage of relapse.
Methods: This project will include a retrospective chart review, reviewing veterans who were initiated on Naltrexone ER therapy from July 2017 to July 2018. Information that will be recorded from the veterans’ chart will include required monitoring prior to initiation and during treatment, reported adverse effects, COWS score, and number of doses received. Other data to be analyzed will include whether absence or relapse was recorded in the veterans chart after receiving initial dose of Naltrexone ER. From this information, we will be able be able to determine if Naltrexone ER initiation protocol could be implemented to increase safety such as recommended labs and monitoring parameters. We will also be able to determine if there are target populations at highest risk for loss of follow-up and relapse.
Results: not applicable
Conclusion: not applicable
Laine Ferrill– PGY1 Pharmacy Resident, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA